Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Other financing activities (2016 - 2025)

Chemours (CC) has 8 years of Other financing activities data on record, last reported at $17.0 million in Q3 2025.

  • For Q3 2025, Other financing activities changed N/A year-over-year to $17.0 million; the TTM value through Dec 2025 reached -$2.0 million, up 89.47%, while the annual FY2025 figure was $21.0 million, 2200.0% up from the prior year.
  • Other financing activities reached $17.0 million in Q3 2025 per CC's latest filing, up from -$22.0 million in the prior quarter.
  • Across five years, Other financing activities topped out at $17.0 million in Q3 2025 and bottomed at -$22.0 million in Q4 2024.
  • Average Other financing activities over 4 years is $1.8 million, with a median of $3.0 million recorded in 2021.
  • Peak YoY movement for Other financing activities: crashed 70.0% in 2021, then crashed 833.33% in 2024.
  • A 4-year view of Other financing activities shows it stood at $3.0 million in 2021, then changed by 0.0% to $3.0 million in 2023, then plummeted by 833.33% to -$22.0 million in 2024, then soared by 177.27% to $17.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other financing activities were $17.0 million in Q3 2025, -$22.0 million in Q4 2024, and $3.0 million in Q4 2023.